Effects of Panax Ginseng in Neurodegenerative Diseases

Overview

Journal J Ginseng Res

Date 2013 May 30

PMID 23717136

Citations 83

Authors

Ik-Hyun Cho

Affiliations

Soon will be listed here.

Abstract

Ginseng, the root of the Panax ginseng, has been a popular and widely-used traditional herbal medicine in Korea, China, and Japan for thousands of years. Now it has become popular as a functional health food and is used globally as a natural medicine. Evidence is accumulating in the literature on the physiological and pharmacological effects of P. ginseng on neurodegenerative diseases. Possible ginseng- or ginsenosides-mediated neuroprotective mechanisms mainly involve maintaining homeostasis, and anti-inflammatory, anti-oxidant, anti-apoptotic, and immune-stimulatory activities. This review considers publications dealing with the various actions of P. ginseng that are indicative of possible neurotherapeutic efficacies in neurodegenerative diseases and neurological disorders such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis and multiple sclerosis.

Citing Articles

A Novel Ginsenoside-Transforming α-L-Rhamnosidase from : Screening, Characterization and Application.

Cui C, Shin D, Hurh B, Im W Biomolecules. 2025; 14(12.

PMID: 39766318 PMC: 11673932. DOI: 10.3390/biom14121611.

Phytochemicals in Parkinson's Disease: a Pathway to Neuroprotection and Personalized Medicine.

Das S, Devi Rajeswari V, Venkatraman G, Ramanathan G Cell Biochem Biophys. 2024; .

PMID: 39537915 DOI: 10.1007/s12013-024-01607-z.

Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.

Xu N, Xing S, Li J, Pang B, Liu M, Fan M PLoS One. 2024; 19(9):e0296424.

PMID: 39302939 PMC: 11414931. DOI: 10.1371/journal.pone.0296424.

Ethyl Acetate Fraction from Root Extract as a Promising Source of Compounds with Anti-Hyaluronidase, Anti-Tyrosinase, and Antioxidant Activity but Not Anti-Melanoma Activity.

Gebalski J, Malkowska M, Wnorowska S, Gawenda-Kempczynska D, Strzemski M, Wojciak M Molecules. 2024; 29(15).

PMID: 39125044 PMC: 11313944. DOI: 10.3390/molecules29153640.

Computational Assessment of the Phytochemicals of Panax ginseng C.A. Meyer Against Dopamine Receptor D1 for Early Huntington's Disease Prophylactics.

Adhikari Subin J, Shrestha R Cell Biochem Biophys. 2024; 82(4):3413-3423.

PMID: 39046621 DOI: 10.1007/s12013-024-01426-2.

References

Bazan N, Palacios-Pelaez R, Lukiw W . Hypoxia signaling to genes: significance in Alzheimer's disease. Mol Neurobiol. 2002; 26(2-3):283-98. DOI: 10.1385/MN:26:2-3:283. View

Beal M, Brouillet E, Jenkins B, Ferrante R, Kowall N, Miller J . Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci. 1993; 13(10):4181-92. PMC: 6576392. View

Ghosh A, Hong L, Tang J . Beta-secretase as a therapeutic target for inhibitor drugs. Curr Med Chem. 2002; 9(11):1135-44. DOI: 10.2174/0929867023370149. View

Shi C, Zhang Y, Zhang Z . [Effect of phosphorylated-ERK1/2 on inducible nitric oxide synthase expression in the substantia nigra of mice with MPTP-induced Parkinson disease]. Nan Fang Yi Ke Da Xue Xue Bao. 2009; 29(1):60-3. View

Leung K, Yung K, Mak N, Chan Y, Fan T, Wong R . Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity. Neuropharmacology. 2006; 52(3):827-35. DOI: 10.1016/j.neuropharm.2006.10.001. View

Damiano M, Galvan L, Deglon N, Brouillet E . Mitochondria in Huntington's disease. Biochim Biophys Acta. 2009; 1802(1):52-61. DOI: 10.1016/j.bbadis.2009.07.012. View

Qian Y, Han H, Hu X, Shi L . Protective effect of ginsenoside Rb1 on beta-amyloid protein(1-42)-induced neurotoxicity in cortical neurons. Neurol Res. 2009; 31(7):663-7. DOI: 10.1179/174313209X385572. View

Xie X, Wang H, Li C, Gao X, Ding J, Zhao H . Ginsenoside Rb1 protects PC12 cells against β-amyloid-induced cell injury. Mol Med Rep. 2011; 3(4):635-9. DOI: 10.3892/mmr_00000308. View

Nah S, Kim D, Rhim H . Ginsenosides: are any of them candidates for drugs acting on the central nervous system?. CNS Drug Rev. 2007; 13(4):381-404. PMC: 6494168. DOI: 10.1111/j.1527-3458.2007.00023.x. View

10.

Conway D, Cohen J . Combination therapy in multiple sclerosis. Lancet Neurol. 2010; 9(3):299-308. DOI: 10.1016/S1474-4422(10)70007-7. View

11.

Selkoe D, Schenk D . Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2002; 43:545-84. DOI: 10.1146/annurev.pharmtox.43.100901.140248. View

12.

Li X, Liu Y, Zhang X, Yuan H, Quan Q . [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease]. Zhongguo Zhong Yao Za Zhi. 2011; 35(24):3339-43. View

13.

Li Y, Ji D, Zhong S, Shi L, Hu G, Chen S . Saponins from Panax japonicus protect against alcohol-induced hepatic injury in mice by up-regulating the expression of GPX3, SOD1 and SOD3. Alcohol Alcohol. 2010; 45(4):320-31. DOI: 10.1093/alcalc/agq034. View

14.

Liu D, Chen Y, Liu Y, Hao B, Zhou B, Wu L . Ginsenoside Rb1 reverses H2O2-induced senescence in human umbilical endothelial cells: involvement of eNOS pathway. J Cardiovasc Pharmacol. 2011; 59(3):222-30. DOI: 10.1097/FJC.0b013e31823c1d34. View

15.

Lee Y, Chung I, Lee I, Kim K, Hong W, Yun Y . Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res. 1997; 17(1A):323-31. View

16.

Joo S, Won T, Lee D . Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vivo. Planta Med. 2005; 71(5):476-81. DOI: 10.1055/s-2005-864145. View

17.

Wang Q, Zheng H, Zhang Z, Zhang Y . [Ginsenoside Rg1 modulates COX-2 expression in the substantia nigra of mice with MPTP-induced Parkinson disease through the P38 signaling pathway]. Nan Fang Yi Ke Da Xue Xue Bao. 2008; 28(9):1594-8. View

18.

Heo J, Lee S, Chu K, Oh M, Park H, Shim J . An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur J Neurol. 2008; 15(8):865-8. DOI: 10.1111/j.1468-1331.2008.02157.x. View

19.

Hills I, Vacca J . Progress toward a practical BACE-1 inhibitor. Curr Opin Drug Discov Devel. 2007; 10(4):383-91. View

20.

Li N, Liu B, Dluzen D, Jin Y . Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J Ethnopharmacol. 2007; 111(3):458-63. DOI: 10.1016/j.jep.2006.12.015. View